Why $55 Billion Is Leaving the Food Industry And Who Pays

In 2019 the market wrote down $15.4 billion in brand value on Oscar Mayer, Kraft, Velveeta, and Lunchables. The products hadn’t failed. The investment in them had. R&D cut to a third of what competitors spent. Marketing hollowed out. When the consumer moved on there was nothing underneath to hold the value.

Five years later, with GLP-1 adoption accelerating and $55 billion in annual revenue at risk, the industry reached for the same playbook. The logic was not wrong. GLP-1 users experience significant muscle loss alongside fat loss. Protein addresses a real clinical need. It is also the cheapest and fastest ingredient to add to an existing product. No new sourcing. No rebuilt flavor architecture. No new manufacturing process. Add a protein isolate, update the nutrition panel, launch a new SKU.

Since 2024, protein SKU proliferation has increased 47% year over year. Cheerios Protein. Velveeta Protein. Oscar Mayer protein bologna. The same products, the same architecture, a new number on the front of the pack. That is not a strategic response to a structural market shift. That is label engineering with a different claim.

The question is why the industry keeps arriving at the same answer. The answer is that there is no system forcing a different one.

Japan has monozukuri. France has terroir. Italy has denominazione di origine controllata. Each is a legally enforced operating system that protects the standard underneath the product from the pressure to optimize it away. The competitive moat is not the brand. It is the discipline the brand is built on. You cannot acquire it, replicate it, or out-market it. You can only build it or buy a company that already has it.

America has no equivalent. The FDA regulates safety. The USDA regulates categories. Neither protects the standard that generates margin or the discipline that survives a market shift.

UPF regulation is a compliance cost, not a competitive strategy. HHS, USDA, and the FDA jointly estimate that approximately 70% of the US packaged food supply qualifies as ultra-processed. Several states are pursuing front-of-pack disclosure requirements. The political pressure is real and the regulatory timeline is accelerating.

But the capital being allocated to meet those requirements is being spent on the wrong problem. Removing titanium dioxide and Red 40 reduces liability. It does not build margin. Reformulating to avoid a disclosure label is defensive spend. It protects the existing architecture without asking whether that architecture can generate repeat purchase in a market that is structurally shifting.

The brands that command the highest acquisition multiples did not get there through compliance investment. Rao’s did not reformulate to meet a regulation. Bachan’s did not audit its label for disclosure risk. They allocated capital to the standard underneath the product and held it there for decades. That is demand creation. The compliance play is traffic capture on a shelf that is losing traffic.

Strategic acquirers were not waiting for the verdict. They were reading the signal years before the earnings calls caught up.

Rao’s Homemade. Same recipe since 1896. Refused private label. Refused to expand distribution beyond what the kitchen could support. $775 million in organic net sales at acquisition, growing 37% year over year without a single compromise to the formulation. Campbell’s paid $2.7 billion in 2023.

Bachan’s Japanese Barbecue Sauce. A grandmother’s recipe. $87 million in annual revenue. Clean label, no compromises, no reformulation, no protein claim. Marzetti paid $400 million, 4.6 times trailing revenue, in early 2026.

McCormick’s $44.8 billion combination with Unilever’s food business adds Hellmann’s, Knorr, and Marmite to a portfolio that already includes Old Bay, Frank’s RedHot, French’s, and Cholula. What McCormick is assembling is not a SKU collection. It is a portfolio of fixed formulations and sourcing standards that predate any marketing campaign ever attached to them. The acquirer is not buying brand equity. It is buying the discipline underneath it.

Nearly $48 billion. 3 transactions. 3 years. One conclusion: the brands with the deepest standards hold the most durable margin.

According to current IPO pipeline data, there are no American food or beverage brands filing for public offerings in 2026. Not one. The brands operating at genuine quality standards, Fly By Jing, Omsom, Fishwife, Chobani, are raising private capital. Private investors are funding what public markets will not yet price. The valuation multiples will follow when the standards prove out.

By 2030, households with GLP-1 users are projected to represent 35% of all food and beverage units sold in the US. The industry is responding with protein SKUs and UPF compliance spend. Both are label strategies. Neither touches the question the winning brands answered before the market arrived: what does this product deliver that makes someone come back without a promotion, a discount, or an engineered craving to override their judgment?

Rao’s answered it in 1896. Bachan’s answered it in a grandmother’s kitchen. The capital markets have been pricing that answer for the last 3 years.